Current treatment of fungal infections is threatened by emerging antifungal drug resistance. In this work, the authors explore the synergistic activity of a host defense peptide mimetic, brilacidin, with caspofungin against a panel of fungal strains.
- Thaila Fernanda dos Reis
- Patrícia Alves de Castro
- Gustavo H. Goldman
